Thank you, Dr. Chang, and the PTCOG community for this honor and for recognizing our work on proton dose intensification for glioblastoma with the Michael Goitein Award.
It has been my great pleasure and honor to serve as the Scientific Program Co-Chair and Clinical Leading Chair for PTCOG for the past four years. I am delighted to witness the advancement of cutting-edge radiation therapy technology and the growth of our talented young colleagues. This will be my last time presenting the Dr. Michael Goitein Award to our outstanding clinical young investigator. @BrianDeMD @PTCOG_OfficialView quoted post on X